Department of Public Health, University "Federico II" of Naples, Naples, Italy.
Clinical Directorate, University Hospital "Federico II" of Naples, Naples, Italy.
Front Public Health. 2023 Jul 13;11:1173482. doi: 10.3389/fpubh.2023.1173482. eCollection 2023.
In Europe, there is still suboptimal tetanus, diphtheria, and acellular pertussis (Tdap) booster coverage. This study aimed to assess coverage status, knowledge, and attitude on Tdap vaccination in healthcare workers (HcWs) of the University Hospital "Federico II" in Naples, Southern Italy, in 2022, to improve current vaccination strategies.
A cross-sectional study was conducted using a validated anonymous questionnaire. Knowledge and attitude were measured as scores. Multivariable logistic and linear regression models were employed to identify correlates of Tdap booster and knowledge and attitude toward the vaccination, as appropriate. Models were controlled for age, sex, profession, department, and job seniority.
A total of 206 questionnaires were administered among HcWs, and 143 (69.4%) were medical doctors. In total, 71 (34.47%) HcWs received the Tdap booster. Those who have worked 5-9 years at the hospital had a 78% lower likelihood of being vaccinated with the Tdap booster (5-9 years-OR: 0.22, CI: 0.06 | 0.85) as compared with newly hired HcWs. No differences in the average knowledge score were found. Other healthcare workers had a lower attitude as compared to medical doctors (Other-Coef. -2.15; CI: -4.14 | -0.15) and, as compared with those who worked in a clinical department, those who worked in a diagnostic-therapeutic department or medical management had 3.1 and 2.0 lower attitude scores, on average, respectively (diagnostic-therapeutic-Coef. -3.12, CI: -5.13 | -1.12; public health-Coef. -1.98, CI: -3.41 | -0.56).
The study findings support the necessity to implement public health strategies and improve knowledge and attitude toward vaccinations and specifically highlight the importance of Tdap booster every 10 years as a prevention tool to protect high-risk populations.
在欧洲,破伤风、白喉和无细胞百日咳(Tdap)加强针的覆盖率仍然不理想。本研究旨在评估意大利那不勒斯大学医院“Federico II”的医护人员(HcWs)在 2022 年的 Tdap 疫苗接种覆盖率、知识和态度,以改进当前的疫苗接种策略。
采用经过验证的匿名问卷进行横断面研究。知识和态度用分数来衡量。使用多变量逻辑和线性回归模型来确定 Tdap 加强针接种的相关因素,以及对疫苗接种的知识和态度,根据需要进行相应的分析。模型控制了年龄、性别、职业、科室和工作年限。
共向 HcWs 发放了 206 份问卷,其中 143 人(69.4%)是医生。共有 71 人(34.47%)接种了 Tdap 加强针。与新入职的 HcWs 相比,在医院工作 5-9 年的 HcWs 接种 Tdap 加强针的可能性降低了 78%(5-9 年-OR:0.22,CI:0.06 | 0.85)。在平均知识得分方面没有差异。与医生相比,其他医护人员的态度较低(其他-Coef. -2.15;CI:-4.14 | -0.15),与在临床科室工作的医护人员相比,在诊断治疗科室或医疗管理部门工作的医护人员的态度平均分别低 3.1 和 2.0 分(诊断治疗-Coef. -3.12,CI:-5.13 | -1.12;公共卫生-Coef. -1.98,CI:-3.41 | -0.56)。
研究结果支持实施公共卫生策略和提高疫苗接种知识和态度的必要性,并特别强调每 10 年接种一次 Tdap 加强针作为保护高危人群的预防工具的重要性。